Skip to main content
. 2016 May 6;2016(5):CD008914. doi: 10.1002/14651858.CD008914.pub3

Poon 2007.

Methods Randomized clinical trial (registered in a clinical trial website of Hong Kong www.hkclinicaltrials.com, no. HKCTR‐12)
 Allocation sequence: random numbers
 Allocation concealment: sealed envelopes. We considered both allocation sequence generation and allocation concealment to be adequate.
 Blinding: not mentioned
Follow‐up: adequate. Lost to follow up: n = 0
Dropouts: n = 0
Informed consent: reported
Intention‐to‐treat analysis: used, but no detailed information
Sample size calculation: performed
Participants Country: Hong Kong, China
Single center: Department of Surgery, The University of Hong Kong, Queen Mary Hospital, between June 2000 and October 2006.
No. randomized: 120
Age: 67 participants ≦ 65 years, 53 participants ≩ 65 years
Gender: Male/Female: 72/48
 Inclusion criteria: Underwent elective PD for benign or malignant pathologies of pancreas or periampullary region.
Exclusion criteria: Underwent emergency PD for trauma. Ongoing acute pancreatitis at the time of operation. Recruited before surgery but were found to have unresectable disease after laparoscopy or laparotomy
Definition of pancreatic fistula: amylase‐rich fluid (amylase concentration 3 times the upper limit of normal serum amylase level) collected from the peripancreatic drains after postoperative day 3 with a drainage volume of 10 mL per day
Conflicts of interest: none
Interventions 120 participants who underwent PD with end‐to‐side pancreaticojejunal anastomosis were randomly assigned to 1 of 2 groups; duct‐to‐mucosa anastomosis was performed in all participants.
 Group 1: An external stent inserted across the PJ anastomosis into the pancreatic duct and brought out externally via the jejunal loop and abdominal wall (n = 60)
 Group 2: No stent in the PJ anastomosis (n = 60)
Outcomes The main outcome measures were:
Pancreatic fistula or leakage
Overall morbidity rate
Hospital mortality rate
Postoperative hospital stay
No. of days to resume oral diet
No. of days on total parenteral nutrition
Notes None
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random numbers
Allocation concealment (selection bias) Unclear risk Sealed envelopes
Blinding (performance bias and detection bias) 
 All outcomes Unclear risk Not mentioned
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Not mentioned
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not mentioned
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Detailed information, and dropouts: n = 0
Selective reporting (reporting bias) Low risk According to the outcomes reported
Other bias Unclear risk Not mentioned